Contact Us

DESTINATION NEWS

Antengene To Present One Oral and Four Abstracts at ASCO 2024

May 30, 2024

Oral Presentation:a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer

URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES

May 30, 2024

The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic

Friso Launches #MovetoGoodPoop Movement to Champion Good Gut Health in Children with Music and Storytelling

May 30, 2024

Homegrown singer-songwriter-producer Derrick Hoh announced as Friso Brand Ambassador for 2024/25 SINGAPORE,May 24,2024--Friso,a leading nutrition formula milk brand with over 150 years of Dutch dairy

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

May 30, 2024

Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.

Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region

May 30, 2024

RIYADH,Saudi Arabia,May 24,2024-- Recently in Riyadh,Newrizon,a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with

Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor

May 30, 2024

SHANGHAI,May 24,2024--Tyligand Bioscience,a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies,announced that the first patient had been dosed

1 ... 333 334 335 336 337 338 339 ... 350